Ardian and Sanofi sign a lease for a substantial office complex located at 46-48 avenue de la Grande Armée in Paris

Ardian

25 November 2020 Real Estate Paris, France

Paris, November 25th, 2020 – Ardian, a world leading private investment house, and French multinational pharma company Sanofi, have agreed on a lease for a post-Haussmann style office complex in Paris. Ardian acquired the office building, located at 46-48 Avenue de la Grande Armée, near Porte Maillot and Place de l’Étoile, in July 2018.

The building, which will cover almost 9,200sqm, comprises two interconnected six- and eight-story buildings. It is a Paris landmark boasting more than a century of history. The project, which is entrusted to Franklin Azzi Architecture, aims to restore the building’s Parisian industrial-era roots from the turn of the 20th century through extensive renovation and modernization – tastefully blending art deco and industrial design.

The project was carefully designed to ensure that it retains authenticity while offering enhanced amenities to create a unique work environment. The building, including the top two terrace floors and distinctive rooftop with emblematic Parisian views, is currently under construction and will be completed in 2022.

Sanofi, with this building as its future world headquarters, intends to offer all its employees a state-of-the-art working environment, to enable greater collaboration between teams, through flexible working facilities.

This choice confirms Sanofi’s commitment to meeting its employees’ changing needs and expectations.

Grande-Armée-Real-Estate

Stéphanie Bensimon, Head of Ardian Real Estate, said: “The lease of the whole building by Sanofi demonstrates Ardian Real Estate’s ability to reinvent office complexes, while preserving their rich heritage.

“While there has been some speculation about the future of offices, this lease is yet another example that high-quality office space remains attractive to large companies. Businesses need to continue to ensure they are offering employees the most suitable conditions to work for the future.”

Jérôme Arnaud, Real Estate Director at Sanofi Group added: “We are delighted to make full use of all the qualities of this completely redesigned and restructured building to offer innovative work spaces that will put a strong emphasis on the fluidity of exchanges and interactions. Our ambition is to make it an unparalleled place to live, work and collaborate.”

Ardian signed the forward-funded sale of the vacant building to institutional investor BNP Paribas Cardif, in May 2019. Ardian had retained the responsibility to market lease agreements related to the building.

This lease follows the recent announcement of the signing of long-term leases on the RIO project, also developed by Ardian Real Estate, in the 8th arrondissement.

LIST OF PARTICIPANTS

  • Ardian

    • Ardian advisors: CBRE, Linklaters, Orfeo
  • Sanofi

    • Sanofi advisors: CBRE Advisory and transaction occupiers, JLL Workplace & Design

ABOUT ARDIAN

Ardian is a world-leading private investment house with assets of US$100bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.
Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.
Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 700 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt. Follow Ardian on Twitter @Ardian

PRESS CONTACTS

ARDIAN – HEADLAND

Gregor Riemann

griemann@headlandconsultancy.com +44 (0)7920 802 627

Categories: News

Tags:

BENCIS ANNOUNCES THE €575 MILLION FINAL CLOSING OF ITS SIXTH FUND

Bencis

23 November 2020

AMSTERDAM, BRUSSELS, DÜSSELDORF
Bencis Capital Partners is pleased to announce that it has raised Bencis VI, reaching the hard cap of €575 million within months after starting the fundraising process.

Continued strong support from existing investors combined with significant interest from new investors from all over the world made for an efficient and successful fundraising. The investor base of Bencis VI consists of pension funds, fund-of-funds, asset managers, insurance companies, family offices and private individuals.

Bencis VI’s investment strategy is unchanged from prior funds. From offices in Amsterdam, Brussels and Düsseldorf the Fund will invest in profitable companies, headquartered in the Benelux and Germany. The targeted companies present multiple opportunities for further growth. Focus will be on companies with operating profits up to €50 million.

Proskauer and Loyens & Loeff acted as legal and tax advisors.

BACKGROUND ON BENCIS CAPITAL PARTNERS
Bencis is an independent investor that supports owners, entrepreneurs and management teams in realizing their growth ambitions, both organically as well as via acquisitions.

Since its inception in 1999, Bencis has invested in 62 companies with an average transaction value of c. €60 million. Furthermore, Bencis has acquired over 190 companies as add-ons to these companies. The current portfolio consists of 24 companies with a combined turnover over €1.9 billion and that together employ approximately 9,600 employees.

For more information on Bencis:
+31 (0)20 5400 940 / info@bencis.com / www.bencis.com

Categories: News

Tags:

Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market

GIMV

De Lier / Eindhoven (NL), 25 November 2020

High-tech scale up Kind Technologies expands its position in the horticulture greenhouse market by acquiring Martin Stolze B.V., an international specialist in the automation of internal transport.
Increasing demand for technology and automation within the horticulture and food processing worldwide
Martin Stolze and Kind Technologies see an increasing demand for automation within the agriculture & food market world-wide. Rising labor costs and scarcity, focus on food safety and the use of data for process improvement are important drivers for the growth strategy of the companies.

Kind

Kind Technologies is a frontrunner in this area and is active within the horticulture with its brands KOAT and Crux Agribotics. It has developed the award-winning SortiPack® system for automatic grading, sorting and packing of organic products, fruits and vegetables, enabling greenhouse growers and packing centers to scale up productivity with less dependence on human labor and to utilize crop data available from the system.

Relevant combined forces
Martin Stolze (http://martinstolze.nl) has been an expert in the internal transport of products in horticulture, distribution- and packaging centers since its establishment in 1991. This long experience, complete product portfolio, own production and service capacity make Martin Stolze a leading manufacturer, supplier and integrator for complete internal transport automation projects. The company has grown strongly in recent years with its internal transport product portfolio including conveyor belts, buffer belts, potting machines, roller conveyors, watering stations, chain- and potting forks, which are sold internationally.

Martin Stolze

Martin Stolze is therefore a valuable extension of the portfolio of Kind Technologies. After this expansion, Kind Technologies consists of more than 200 engineers and technicians dedicated to bringing its technologies to the market. Managing Director Wido Kruijswijk will continue to lead Martin Stolze with the existing team. Martin Stolze with its 57 employees will remain based in De Lier (The Netherlands) and will continue its activities under its current name. Martin Stolze will remain involved as external advisor.

“Essential to further strengthen the growth and continuity of Martin Stolze”
“I am very happy and proud that the Kind Technologies group sees our added value and potential’ says Martin Stolze, the former owner and founder of the company. ‘It was key for me, to guarantee the continuity of the company for our employees, customers and other stakeholders’. ‘By joining this innovative high-tech group, we can access their experience in managing growth and further professionalize our business processes, attract new talent and expand our offering’.

“Enormous potential in automating horticulture and packaging centers worldwide”
‘With this steppingstone expansion, we accelerate our growth strategy within the horticulture’, says Alex E. Kind, CEO of Kind Technologies. ‘We see enormous potential in automating the typical manual processes within greenhouses and packing centers globally’. ‘With this acquisition we secure our presence in the greenport region Westland, the world’s most innovative region in the field of greenhouse horticulture’. ‘We are positioning ourselves to be the system supplier of choice for the full horticulture value chain including growers, greenhouse builders, installation and automation companies. Our strategy is based on significant investments in R&D, services and strategic partnerships within the industry combined with strategic acquisitions such as Martin Stolze and KOAT in 2019’.
No further details will be disclosed.

ABOUT Kind Technologies
Kind Technologies is as high-tech group specialized in industrial automation with Robotics, Computer Vision and AI. As Original Equipment Manufacturer (OEM) it delivers systems worldwide to the Agriculture & Food and Pharma markets. In these markets, where quality cannot be compromised, its technology warrants patient- and food safety.
Kind Technologies is on a mission to contribute to a better world where plant, food and medicines are better distributed over the world and resource scarcity is addressed through advanced automation. With our technology, we want to contribute to a world where the population can grow, without anyone having to suffer from hunger. A world where availability of authentic medicines is a basic provision. Our roadmap around Industrial Automation, Robotics, Computer Vision and AI enable more efficient and scalable production processes where quality is safeguarded and all intermediate steps can be tracked and traced across value chains.
Leading brands and members of the group are Beltech, Vimec Applied Vision Technology, Crux Agribotics and KOAT.
Kind Technologies is active worldwide and headquartered in Eindhoven, The Netherlands, with another office and production location in Someren, The Netherlands. In 2018, Gimv N.V. (Euronext: GIMB) joined as shareholder to provide Kind Technologies with capital and support to realize its growth strategy based on organic growth combined with strategic add-on acquisitions.
More information on Kind Technologies can be found on www.kindtechnologies.nl
More information on Crux Agribotics can be found on www.cruxagribotics.com and www.sortipack.com
More information on KOAT can be found on www.koat.nl
Be Kind to the world.

ABOUT Martin Stolze
Since 1991 Martin Stolze has developed into a total supplier for the automation of internal transport for the horticultural greenhouse sector. Martin Stolze represents service and quality. As a result, Martin Stolze has already served thousands of satisfied customers all over the world.
In its own factory a complete product portfolio is designed, produced and assembled including conveyor belts, buffer belts, potting machines, roller conveyors, watering stations and many other products to make the work in and around greenhouses easier. The modular and scalable product portfolio can be combined in total projects and equipped with full computer control. Martin Stolze also offers value-added services to assist and guide OEMs, partners, resellers and customers in realizing complete automation projects. Martin Stolze also has a rental department in which a large part of the product portfolio can be rented for a defined period.
We are happy to help you by ‘taking the work out of your hands’.

More information on Martin Stolze can be found on www.martinstolze.nl

For further information please contact:
Charlotte Jannes, Kind Technologies
T: +31 40 747 0401 – E: Charlotte.jannes@kindtechnologies.nl

Sascha Veltrop, Martin Stolze
T: +31 17 451 8113 – E: marketing@martinstolze.nl

Categories: News

Tags:

Japan’s Mitsui Sumitomo to invest $350 million in insurance startup Hippo

Horizons Ventures

NEW YORK (Reuters) – Mitsui Sumitomo Insurance Company, a subsidiary of Japan’s MS&AD Insurance Group, will invest $350 million in U.S. home insurance technology company Hippo Enterprises to fund its next stage of growth, the companies said in a joint statement on Tuesday.

Mitsui bought a convertible note in Hippo that will turn into an equity stake the next time it raises new funds, Hippo Chief Executive Officer Assaf Wand told Reuters in an interview.

MS&AD’s venture arm was part of Hippo’s Series E funding round that was announced in July, and the new investment – which is accompanied by a plan to sign a reinsurance agreement with Mitsui Sumitomo – builds on that partnership.

Hippo was valued at $1.5 billion in July, although Wand noted this figure was now outdated because of market developments and the growth of the business. He declined to disclose an updated valuation.

“We have been very thoughtful on the people that we’ve bought into the capital structure and how can they help us build the biggest franchise,” said Wand.

Insurance technology startups such as Hippo have been growing rapidly in the pandemic as more consumers seek quotes and policies remotely.

Investors have funneled billions of dollars into the public offerings for Lemonade Inc, Root Inc and SelectQuote Inc this year, at significantly higher valuations than traditional insurance companies.

Asked if Hippo could become a publicly traded company in 2021, raise new funds from private investors or seek a sale, Wand said the company was evaluating all these options.

The Mitsui Sumitomo investment will allow Hippo to continue growing its product range and expand in new U.S. markets. Hippo aims to be able to offer services to about 95% of the U.S. population in the next year, Wand said.

Hippo’s other investors include Comcast Ventures, and technology-focused investment firms Dragoneer and BOND.

(Reporting by David French in New York; Editing by Rashmi Aich)

AddSecure enters the video surveillance market with the acquisition of International Security Group GmbH

Castik Capital

By entering this fast-growing market and adding video Surveillance-as-a-Service to its offering, AddSecure expects the acquisition to support the company’s ambitious growth strategy.

AddSecure, a leading European provider of premium IoT solutions with a focus on secure critical communications and data, announced today that it has entered into an agreement to acquire International Security Group GmbH, a leading German innovator in technology-driven video Surveillance-as-a-Service. ISG offers a comprehensive portfolio of mobile video surveillance solutions marketed as Video Guard to customers within industries such as construction, logistics and infrastructure.

With the acquisition, AddSecure enters the attractive video surveillance market, a growth market with vast potential. The mobile video surveillance market in Germany, ISG’s core market, is expected to grow at over 30% p.a. with similar growth rates possible in other European geographies given the markets are relatively nascent.

The joint mission is to enhance the safety and security across industries such as construction, utilities, transportation and more, with the objective to become a leading European provider of video Surveillance-as-a-Service.

“The acquisition of ISG boosts AddSecure’s reach in the IoT and secure critical communications and data space, and enhances our offering with the addition of advanced video surveillance technology. Entering into this growing market is a logical next step to support our ambitious growth strategy, and fits perfectly with our extensive knowledge of security and safety and our current offering of smart solutions,” said Stefan Albertsson, CEO of AddSecure.

“We are excited to join the AddSecure organization with its expansive growth strategy and pan-European footprint that will open new opportunities for the Video Guard product range,” said Jörn Windler, Managing Director of International Security Group.

Jörn Windler will remain as the Managing Director of the business post-acquisition and will be instrumental in integrating the video surveillance offering into AddSecure.

For more information, please contact:

Kristina Grandin, Director Corporate & Marketing Communication, AddSecure
Mobile: +46 70 689 52 08, kristina.grandin@addsecure.com

About International Security Group

International Security Group is a leading German innovator in technology-driven video surveillance-as-a-Service. The company offers customers, in Germany and abroad, a comprehensive portfolio of mobile video surveillance solutions. The offering, marketed as Video Guard, helps customers to keep their assets safe in industries such as construction, energy and infrastructure.

The focus is on self-developed security solutions that meet the highest quality standards. Technical know-how, and a high degree of innovative strength form the basis for this. Among other things, the portfolio includes national and international security services with security technology and personnel.

The company is based in Hesel in Lower Saxony, Germany, and has a Danish subsidiary in Copenhagen.

About AddSecure

AddSecure is a leading European provider of premium IoT solutions with a focus on secure critical communications and data. More than 100,000 customers within the security and safety industry, rescue services, building security and automation, digital care, transport and logistics, utilities, smart cities, and more, safeguard their life and business-critical applications with solutions from AddSecure. This helps save lives, protect property and vital societal functions, and drives business.

The secure and reliable end-to-end solutions within the business units Smart Alarms, Smart Care, Smart Grids, Smart Rescue, and Smart Transport, help make the world a safer and smarter place.

The company, founded in the early 1970s, today employs more than 830 staff in 15 countries. AddSecure is headquartered in Stockholm, Sweden, and has regional offices as well as a network of distributors around Europe.

AddSecure is majority-owned by Funds managed by Castik Capital, a European private equity fund with a long-term approach to value creation, founded in 2014.

Categories: News

Tags:

Janes Acquires Global Platforms & Systems business from Avascent

Montagu

24th November 2020

Janes has today announced an agreement to acquire the defence market analytics business – also known as Global Platforms and Systems (“GPS”) – from Avascent to support its industry intelligence solutions and enhance the offering it provides to customers.

This acquisition comes as we continue to build on the momentum we have created since becoming an independent business and ensures that we will continue to deliver the objective open-source intelligence and analytics that our customers rely upon.

Blake Bartlett, CEO of Janes

“I’m delighted to announce the acquisition of GPS from Avascent – it’s a great addition to our portfolio of trusted open-source defence intelligence solutions and allows us to enhance our position as the leading provider of defence market forecasts worldwide,” said Blake Bartlett, CEO at Janes. “This acquisition comes as we continue to build on the momentum we have created since becoming an independent business and ensures that we will continue to deliver the objective open-source intelligence and analytics that the world of defence and security relies upon.”

“This deal brings a highly complementary capability into the Janes ecosystem of connected data that our customers trust in their most critical decisions,” said Doug Dixon, President of Aerospace and Defence Industry at Janes. “We’re focused on getting our customers the right data in the right structure to underpin the analytics they need to operate in the modern national security environment.”

“In Janes, we have found a partner that can take the GPS business to the next level while we continue to focus and invest in our core strategy consulting business,” said Steve Irwin, President of Avascent. “Clients who have come to rely on GPS and its custom features will experience no change in the quality of the product or the responsiveness of the client service. Indeed, clients who have wanted closer integration between GPS and other data resources can now look forward to the prospect of more powerful tools to support their strategy, corporate development, and business development efforts.”

The deal between Janes and Avascent also includes a collaboration agreement through which the two firms can pursue opportunities where their joint capabilities will provide clients with unparalleled insights and advice on critical defence and security issues.

Janes expects completion of the acquisition in January 2021 subject to customary conditions.

Categories: News

Tags:

Eurazeo announces the completion of the sale of its stake in Iberchem

Eurazeo

Paris, November 24, 2020

Eurazeo Capital has announced today the completion of the sale of the entire share capital of Iberchem in which Eurazeo has been a shareholder since July 2017, to Croda International Plc (LON: CRDA).

Over the last three years, Iberchem has significantly reinforced its position as a leading global producer of fragrances and flavours focusing on local and regional brands in high-growth international markets. Thanks to its strategic positioning, the company combined a best-in-class organic growth of +15% per year sales over the last 10 years and targeted M&A, with the support of Eurazeo network, notably in China and Malaysia.

Transaction sales proceeds for Eurazeo and its investors partners total € 564m and € 383m for Eurazeo only, representing a return on its initial investment of 2.1x and an Internal Rate of Return (IRR) of approximately 25%. This price is more than 30% above the one reflected in our NAV as of 30 June 2020 (or about 1.25€ by Eurazeo share).
Ramón Fernández, Founder and Chief Executive Officer, Iberchem, said:
“ It has been a great pleasure to work with Eurazeo teams during these last years. We have been able to take advantage of their professional experiences and their wide network, as well as their in-depth understanding of Iberchem’s model specificities and strengths. ”

Marc Frappier, Managing Partner, Head of Eurazeo Capital, said:
“We would like to thank the management team and employees of Iberchem, led by Ramón Fernández, CEO and founder, for our fantastic partnership over the last 3 years. We were delighted to help them further accelerate their global growth story. We wish them all the success they deserve in the next phase of their journey with the support of Croda, the perfect partner for Iberchem’s future development.”

About Eurazeo
• Eurazeo is a leading global investment group, with a diversified portfolio of €18.8 billion in Assets Under Management, including €13.3 billion from third parties, invested in over 430 companies. With its considerable private equity, real estate and private debt expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.

• Eurazeo has offices in Paris, New York, Sao Paulo, Seoul, Shanghai, London, Luxembourg, Frankfurt, Berlin and Madrid
• Eurazeo is listed on Euronext Paris.
• ISIN: FR0000121121 – Bloomberg: RF FP – Reuters: EURA.PA

EURAZEO CONTACTS

HEAD OF INVESTOR RELATIONS

e–mail: pbernardin@eurazeo.commail: pbernardin@eurazeo.com
Tel: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT
HEAD OF COMMUNICATIONS

e–mail: mail: vchristnacht@eurazeo.comvchristnacht@eurazeo.com
Tel: +33 1 44 15 76 44

DAVID STURKEN
MAITLAND/AMO
e-mail: dsturken@maitland.co.uk
Tel: +44 (0) 7990 595 913

Categories: News

Tags:

Ardian enters into exclusive negotiations to support the development of Inovie, the leading independent medical diagnostic provider in France

Ardian

24 November 2020 Buyout Paris, France

Paris, November 24th, 2020 – Inovie, the leading independent medical diagnostic provider in France, and Ardian, a world-leading private investment house, announce today that they have entered into exclusive negotiations for the acquisition of a minority stake by Ardian in Labosud, Inovie group’s lead company. The entry was approved by a very large majority of the group’s shareholding biologists (93% of votes in favor), and who will reinvest significant capital as part of the transaction, during a General Assembly dated November 19th, 2020. The transaction remains subject to the consultation processes of the relevant Labosud employee representative bodies in accordance with applicable law.

Founded in 2010, Inovie has undergone significant external growth to become the leading independent medical diagnostic provider in France and a key player across Southern and Central France specifically. With a strong local footprint of 19 multi-site laboratories spread over five key regions (Occitanie, Provence-Alpes-Côte-d’Azur, Nouvelle Aquitaine Auvergne Rhône Alpes and Centre Val de Loire), Inovie’s biologists and 4,500 employees deliver high-standard clinical pathology testing to more than 46,000 patients daily. Inovie has also played a leading role in innovation, notably through their work in four areas of specialty: fertility (Inovie Fertilité), genomics (Imagenome), anatomopathology (Inopath) and veterinary services (Inovie Vet).

As part of the partnership with Ardian, Inovie will maintain independence and further develop its renowned model. The management team will remain in charge of business operations, and the biologists will retain a majority stake in Labosud’s as well as and voting rights, whilst continuing to be the cornerstone of Inovie’s operating excellence.

Ardian’s investment aims to make Inovie a leader in an increasingly competitive market, and one of the best-positioned companies to face current and future public health challenges. With Ardian as a shareholder, Inovie will be able to pursue an ambitious external growth and diversification strategy based on the development of its specialties, an acceleration of its digital strategy, and international expansion.

Georges Ruiz, President of Inovie, said: “To be able to keep up with future challenges in clinical pathology, notably in terms of development, diversification and innovation, we had to evolve our model and find new resources whilst staying close to our roots. We are very pleased to have built a project for the future with Ardian, which stays true to our core values relating to better supporting our patients in the course of their care by bringing together the best practitioners in clinical pathology. This is thanks to the dedication and competence of our teams in their daily work.“

Philippe Poletti, CEO of Ardian France, Member of the Executive Committee and Head of Ardian Buyout: “We are honored that Inovie’s biologists have placed their trust in Ardian and share our ambition for the development plan that we have built over the past 9 months with Georges Ruiz, the President of Inovie, and his teams.”

Nicolas Darnaud, Managing Director in Ardian Buyout team, complements: “In a few years’ time, Inovie was able to continuously provide their essential contribution to clinical pathology in France, notably through the delivery of their specialized centres, which are a major asset in an increasingly competitive market. With our partnership, we will begin a new chapter in the group’s development by leveraging its existing strengths and supporting its principles and core values, as well as contributing new resources. We believe that by doing this, we will fully equip Inovie to face the challenges in clinical pathology for the years to come.”

LIST OF PARTICIPANTS

  • Ardian

    • Nicolas Darnaud, Edouard Level, Edmond Delamalle, Pierre Casas
    • Buyer M&A advisors: Rothschild & Co. (Laurent Baril, Robert Rozemulder, Youssef Bouallou, Pierre-Yves Lebot), Edmond de Rothschild Corporate Finance (Pierre Boscher, Arnaud Petit, Aurélien Bouvier, Victor Auguin-Rougier)
    • Buyer legal advisors : Latham & Watkins (Gaëtan Giannasso, Michael Colle (corporate), Xavier Farde, Carla-Sophie Imperadeiro (financing), Xavier Renard, Thomas Claudel (structuring))
    • Buyer strategic DD: Bain & Company (Jérôme Brunet, Agnès Houdaille, Ghofrane Maaroufi)
    • Buyer financial DD: EY (Hervé Jauffret, Elsa Abou Mrad, Vincent Magaud)
    • Buyer operational DD: EY (Olivier Sibenaler, Olivier Nicolle, Paul-Louis Royer)
    • Buyer legal, tax, labor DD: EY (Virginie Lefebvre-Dutilleul, Christine Salès (legal), Lionel Benant, Nevenna Teodorova (tax), Sophie Muyard, Taïna Celestin (labor))
    • Buyer ESG DD: Indefi (Emmanuel Parmentier, Charlotte Salmon)
    • Buyer insurance DD: Siaci Saint Honoré (Pierre de Rochebouët, Anne Rougerie)
  • Inovie

    • Inovie’s Executive Committee: Georges Ruiz, Sébastien Floret, Dominique Forte, Thomas Hottier, Xavier Huc, Benoît Ponseillé
    • Vendor M&A advisor: BNP Paribas (Marc Walbaum, Alexandre Greco, Xavier Caron, Hui Zhao)
    • Vendor legal advisor: Weil Gotshal & Manges (Jean Beauchataud, Romain Letard, Michaël Koubi)
    • Vendor financial DD: PwC (Philip Dykstra, Frédéric Spielrein, Pierre-Mikhaël Voyer)
    • Vendor legal DD: Weil, Gotshal & Manges (Jean Beauchataud, Romain Letard, Michaël Koubi)
    • Vendor tax, labor DD: PwC (Jean-Philippe Brillet, Mathieu Echallier, Jihanne Flegeau-Kihal (fiscal), Bernard Borrely, Pauline d’Humières (social))
    • Management financial advisor: Callisto Finance (Vincent Aymé, Tancrède Caulliez)

ABOUT ARDIAN

Ardian is a world-leading private investment house with assets of US$100bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.
Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.
Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 700 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of around 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt. Follow Ardian on Twitter @Ardian

Press contacts

ARDIAN – Headland

Gregor Riemann

griemann@headlandconsultancy.com +44 (0)7920 802 627

Categories: News

Tags:

Spring Marketing Capital invests in Purplle from its maiden fund

Verlinvest

Purplle is backed by Blume Ventures, IvyCap Ventures, JSW ventures – and last year it raised more than $30 million from Goldman Sachs and Verlinvest.

Branding and marketing-focused fund Spring Marketing Capital has made its first investment of $1 million from its maiden fund in Purplle, a beauty e-commerce platform.

Purplle is backed by Blume Ventures, IvyCap Ventures, JSW ventures.

It raised more than $30 million last year from Goldman Sachs and Verlinvest, the Belgian investment holding company, in its Series C funding round.

Launched in 2011, Purplle has a revenue run rate of around Rs 500 crore as on date and is earnings before interest, tax, depreciation and amortisation (Ebitda) break even, said Manish Taneja, co-founder, Purplle.

According to Taneja, the company might soon look to expand to other countries. “Unlike other creative agencies that work ..
It has some startups founders and other GPs as other backers.

Launched last year by Raja Ganapathy, the former chief marketing officer of Sequoia Capital India, along with Vineet Gupta, ex-group chief executive of DDB Mudra and Arun Iyer, former chairman of Lowe Lintas, Spring looks to invest in early-stage, consumer-facing startups.

“We have spent a lot of time with the Purplle founders and are very impressed with their vision to create an online beauty platform out of India.  ..

People in this post: Arjun Anand

Portfolio companies in this post: Purplle

Categories: News

Tags:

Janes Acquires Global Platforms & Systems business from Avascent

Montagu

Janes has today announced an agreement to acquire the defence market analytics business – also known as Global Platforms and Systems (“GPS”) – from Avascent to support its industry intelligence solutions and enhance the offering it provides to customers.

This acquisition comes as we continue to build on the momentum we have created since becoming an independent business and ensures that we will continue to deliver the objective open-source intelligence and analytics that our customers rely upon.

Blake Bartlett, CEO of Janes

“I’m delighted to announce the acquisition of GPS from Avascent – it’s a great addition to our portfolio of trusted open-source defence intelligence solutions and allows us to enhance our position as the leading provider of defence market forecasts worldwide,” said Blake Bartlett, CEO at Janes. “This acquisition comes as we continue to build on the momentum we have created since becoming an independent business and ensures that we will continue to deliver the objective open-source intelligence and analytics that the world of defence and security relies upon.”

“This deal brings a highly complementary capability into the Janes ecosystem of connected data that our customers trust in their most critical decisions,” said Doug Dixon, President of Aerospace and Defence Industry at Janes. “We’re focused on getting our customers the right data in the right structure to underpin the analytics they need to operate in the modern national security environment.”

“In Janes, we have found a partner that can take the GPS business to the next level while we continue to focus and invest in our core strategy consulting business,” said Steve Irwin, President of Avascent. “Clients who have come to rely on GPS and its custom features will experience no change in the quality of the product or the responsiveness of the client service. Indeed, clients who have wanted closer integration between GPS and other data resources can now look forward to the prospect of more powerful tools to support their strategy, corporate development, and business development efforts.”

The deal between Janes and Avascent also includes a collaboration agreement through which the two firms can pursue opportunities where their joint capabilities will provide clients with unparalleled insights and advice on critical defence and security issues.

Janes expects completion of the acquisition in January 2021 subject to customary conditions.

Categories: News

Tags: